FindTrial
Sign In

Comparision of pain relief after total knee replacement surgery between Levobupivacaine(local anaesthetic drug) alone versus Levobupivacaine with Dexmedetomedine(additive)

Ultrasound guided continuous adductor canal block for postoperative pain relief after total knee arthroplasty with levobupivacaine versus levobupivacaine with dexmedetomidine- A randomized Clinical study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037439
Enrollment
80
Registered
2021-10-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: continuous adductor canal block: continuous adductor canal block for post operative pain relief after total knee replacement surgery Control Intervention1: Levobupivacaine versus Levobu

Sponsors

KIMS MEDICAL COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective TKR surgeries 2. Aged between 18 years and 70 years of age 3. American Society of Anesthesiologists (ASA) class 1 to 3

Exclusion criteria

Exclusion criteria: 1. Allergy to local anaesthetic 2. Intellectual impairment or psychiatric condition precluding adequate communication 3. Bleeding disorder, trauma and infection near the procedure area.

Design outcomes

Primary

MeasureTime frame
PRIMARY-1.Duration of analgesia. SECONDARY-1. 24 hour opioid consumption, 2.success of early ambulation, 3.patient satisfaction, 4.Any adverse effects or complications. Timepoint: 24 HOURS—

Secondary

MeasureTime frame
SECONDARY-1.24 hour opioid consumption, 2.success of early ambulation, 3.patient satisfaction, 4.Any adverse effects or complications. Timepoint: 24 HOURS—

Countries

India

Contacts

Public ContactKISHORE KEERTHY N

KIMS MEDICAL COLLEGE,BANGALORE

drkishorekeerthy@gmail.com9739083518

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026